{
    "N/R/U": null,
    "Applicant": "Hospira Inc., a Pfizer Company",
    "BLA Number": "761080",
    "Proprietary Name": "Nivestym",
    "Proper Name": "filgrastim-aafi",
    "BLA Type": "351(k) Biosimilar",
    "Strength": "300MCG/ML",
    "Dosage Form": "Injection ",
    "Route of Administration": "Intravenous, Subcutaneous ",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "20-Jul-18",
    "Ref. Product Proper Name": "filgrastim",
    "Ref. Product Proprietary Name": "Neupogen",
    "Supplement Number": null,
    "Submission Type": "Original",
    "License Number": "1974",
    "Product Number": "1",
    "Center": "CDER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": null
}